1. Renal risk scores: Progress and prospects
M.W. Taal, B.M. Brenner 
Kidney International 
Volume 73, Issue 11, Pages (June 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan Meier curve showing the incidence of ESRD among patients with type 2 diabetes and diabetic nephropathy included in the Reduction of Endpoints in NIDDM with Angiotensin II Antagonist Losartan (RENAAL) Study, stratified into quartiles of a risk score derived from baseline serum creatinine, urine albumin/creatinine ratio, serum albumin, and hemoglobin.
Kidney International  , DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions